share_log
Reuters ·  03:45
Pfizer: Sasanlimab in Combination With Bcg Improves Event-Free Survival in Patients With Bcg-Naïve, High-Risk Nonmuscle Invasive Bladder Cancer
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment